Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study.

@article{Pipinikas2007MeasurementOB,
  title={Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study.},
  author={Christodoulos P. Pipinikas and Sabarinath B Nair and Roger Sinclair Kirby and Nicholas D. Carter and Christiane D. Fenske},
  journal={Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals},
  year={2007},
  volume={12 5},
  pages={541-57}
}
The use of serum prostate-specific antigen (PSA) measurements necessitates biopsies for accurate prostate cancer (CaP) diagnosis. Overall efficiency of accurate diagnosis, when PSA levels are used alone, is less than 60%. E2F3 was evaluated as an alternative biomarker using patient blood samples. Expression levels were measured by quantitative reverse… CONTINUE READING